Methods for transmembrane treatment and prevention of otitis media

Details for Australian Patent Application No. 2005282571 (hide)

Owner Piedmont Pharmaceuticals, LLC

Inventors Campbell, William, R.

Agent Spruson & Ferguson

Pub. Number AU-A-2005282571

PCT Pub. Number WO2006/029074

Priority 60/607,175 03.09.04 US; 60/649,926 03.02.05 US

Filing date 2 September 2005

Wipo publication date 16 March 2006

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/029074 Priority application(s): WO2006/029074

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282572-Fibrate compounds having PPAR agonist activity

2005282565-Content and channel aware object scheduling and error control